The recent imposition of a 27 per cent reciprocal tariff on Indian exports by the United States, while exempting the ...

The recent imposition of a 27 per cent reciprocal tariff on Indian exports by the United States, while exempting the ...

Pharmaceutical exports from Ireland to the United States could face punitive tariffs "within the next few weeks," according ...

Maria Lowe, Ph.D., associate vice president of Pharmaceutical Intelligence at Institute for Clinical and Economic Review ...

Pharmaceutical products will be spared from sweeping tariffs on major U.S. trade partners for now, a small victory for drug companies who have been lobbying for an exemption from levies.

The pharmaceutical industry avoided immediate tariffs under President Donald Trump’s latest trade actions, though future levies remain a possibility. Here are four things to know: ...

Indian pharmaceutical exports to the U.S. were valued at approximately USD 8 billion, with the industry witnessing an 8 percent compound annual growth rate (CAGR) over FY15-24.

Due to this uncertainty, InCred is shifting its portfolio towards healthcare businesses with little or no US exposure.

After threatening to impose “25% or higher” tariffs on foreign-made pharmaceuticals along with automobiles and semiconductors ...

Steinkühler: AI presents a tremendous opportunity in the field of finance, primarily because it facilitates the use and ...

With an increasing demand for NHS services, technology is being positioned as a critical tool in eliminating inefficiencies ...

4 analysts have shared their evaluations of Collegium Pharmaceutical COLL during the recent three months, expressing a mix of bullish and bearish perspectives. In the table below, you'll find a ...